Clinical Trials Directory

Trials / Unknown

UnknownNCT02104297

Effect of Deksmedetomidine and Remifentanil in Extubation Agitation

The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To compare the effect of two different agents deksmedetomidine, remifentanil and placebo, agitation and recovery condition, on nasal septum operation.

Detailed description

Nasal septum operation cause agitation because of nasal package. This research aims determine which agent , deksmedetomidine remifentanil or placebo, is more beneficial to the patient.

Conditions

Interventions

TypeNameDescription
DRUGdeksmedetomidinedeksmedetomidine infused during operation 0.2 mcg/kg/hour
DRUGRemifentanilRemifentanil infused during operation 0.2 mcg/kg/min
DRUGSalineDuring operation saline infused equal volüme of deksmedetomidine and remifentanil

Timeline

Start date
2014-04-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2014-04-04
Last updated
2014-04-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02104297. Inclusion in this directory is not an endorsement.